ZIOPHARM Oncology, Inc. (ZIOP) Misses Q3 EPS by 2c, Announces $50M Stock Offering
Tweet Send to a Friend
ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) reported Q3 EPS of ($0.20), $0.02 worse than the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
